ZoneOne Pharma

ZoneOne Pharma is a private U.S. pharmaceutical company focused on rationally designed liposomal and nanomedicine-based therapies for chronic disorders. Publicly available descriptions indicate that the company has been developing a non-irritating ocular treatment for cystinosis-related corneal cystine crystal accumulation, and has also described liposomal deferoxamine approaches for iron-overload disorders. The company appears to position itself as a drug-delivery and formulation platform business built around proprietary liposomal technologies intended to improve dosing, tolerability, and patient compliance. Available sources suggest a small, early-stage organization headquartered in San Francisco with no clear evidence of commercial products or clinical-stage programs.